{
"@context": "https://schema.org",
"@graph": [
{
"@type": "WebPage",
"@id": "https://www.fortrea.com/insights/smarter-faster-better-how-ai-reshaping-neuroscience-clinical-trials#webpage",
"url": "https://www.fortrea.com/insights/smarter-faster-better-how-ai-reshaping-neuroscience-clinical-trials",
"name": "Smarter, faster, better: How AI is reshaping neuroscience clinical trials",
"description": "This Fortrea white paper explores AI in neuroscience clinical trials and how artificial intelligence can help reduce complexity, accelerate timelines, and improve operational efficiency across neurological research programs. The content focuses on AI in neuroscience clinical trials, patient recruitment optimization, site selection strategies, protocol design improvements, trial efficiency, cost reduction approaches, and neuroscience clinical development associated with complex neurological studies. The white paper highlights factors related to high screening failure rates, disease heterogeneity, subjective endpoints, study delays, and operational challenges affecting neuroscience clinical research. Fortrea discusses scientific and operational perspectives designed to support more efficient study planning, strengthen trial execution strategies, and improve decision-making across neuroscience clinical development programs. By integrating artificial intelligence with neuroscience clinical trial planning, recruitment strategies, and operational execution approaches, the white paper provides insights into AI in neuroscience clinical trials and technology-enabled strategies that can help accelerate neuroscience research and clinical development."
},
{
"@type": "BreadcrumbList",
"itemListElement": [
{
"@type": "ListItem",
"position": 1,
"name": "Home",
"item": "https://www.fortrea.com"
},
{
"@type": "ListItem",
"position": 2,
"name": "Insights",
"item": "https://www.fortrea.com/insights/"
},
{
"@type": "ListItem",
"position": 3,
"name": "Smarter, faster, better: How AI is reshaping neuroscience clinical trials",
"item": "https://www.fortrea.com/insights/smarter-faster-better-how-ai-reshaping-neuroscience-clinical-trials"
}
]
},
{
"@type": "Organization",
"@id": "https://www.fortrea.com/#organization",
"name": "Fortrea",
"url": "https://www.fortrea.com",
"description": "Fortrea is a global contract research organization built on more than 30 years of experience and one of the earliest CRO legacies in the industry—as Covance, evolving within Labcorp, and now operating as Fortrea. With deep expertise across Phase I–IV clinical trials, Fortrea advances clinical research through a patient-centric approach that prioritizes meaningful outcomes, stronger site–CRO relationships, and operational excellence. Fortrea partners with biopharmaceutical, biotech, and medical device companies to advance therapies through every stage of clinical development. This commitment is further reinforced by the launch of Fortrea Intelligent Technology, enabling smarter, more connected, and data-driven clinical development. Through Fortrea Intelligent Technology, the organization is advancing data-driven, technology-enabled clinical development to improve speed, quality, and patient outcomes. It is shaped by experience, innovation, and a commitment to raising standards in clinical research—focused on accelerating development and helping bring life-changing treatments to patients around the world.",
"logo": "https://www.fortrea.com/sites/default/files/2025-05/fortrea-logo-without-background.png",
"sameAs": [
"https://www.linkedin.com/company/fortrea",
"https://www.threads.net/@fortreacro",
"https://twitter.com/fortrea",
"https://www.youtube.com/@Fortrea/",
"https://www.facebook.com/Fortrea-104143099267108",
"https://www.instagram.com/fortreacro"
]
},
{
"@type": "Article",
"@id": "https://www.fortrea.com/insights/smarter-faster-better-how-ai-reshaping-neuroscience-clinical-trials#whitepaper",
"mainEntityOfPage": {
"@id": "https://www.fortrea.com/insights/smarter-faster-better-how-ai-reshaping-neuroscience-clinical-trials#webpage"
},
"headline": "Smarter, faster, better: How AI is reshaping neuroscience clinical trials",
"description": "This Fortrea white paper explores AI in neuroscience clinical trials and how artificial intelligence can help reduce complexity, accelerate timelines, and improve operational efficiency across neurological research programs. The content focuses on AI in neuroscience clinical trials, patient recruitment optimization, site selection strategies, protocol design improvements, trial efficiency, cost reduction approaches, and neuroscience clinical development associated with complex neurological studies. The white paper highlights factors related to high screening failure rates, disease heterogeneity, subjective endpoints, study delays, and operational challenges affecting neuroscience clinical research. Fortrea discusses scientific and operational perspectives designed to support more efficient study planning, strengthen trial execution strategies, and improve decision-making across neuroscience clinical development programs. By integrating artificial intelligence with neuroscience clinical trial planning, recruitment strategies, and operational execution approaches, the white paper provides insights into AI in neuroscience clinical trials and technology-enabled strategies that can help accelerate neuroscience research and clinical development.",
"genre": "White Paper",
"image": {
"@type": "ImageObject",
"url": "https://www.fortrea.com/sites/default/files/2025-09/smarter-faster-better-ai-neuroscience-clinical-trials.jpg"
},
"author": {
"@type": "Organization",
"name": "Fortrea",
"url": "https://www.fortrea.com/"
},
"publisher": {
"@id": "https://www.fortrea.com/#organization"
},
"datePublished": "2025-09-18",
"dateModified": "2025-09-18",
"encoding": {
"@type": "MediaObject",
"contentUrl": "https://www.fortrea.com/sites/default/files/2025-09/smarter-faster-better-ai-neuroscience-clinical-trials.pdf",
"encodingFormat": "application/pdf"
}
}
]
}